Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

BIOMARIN PHARMACEUTICAL INC (BMRN)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21Dec-31-20
   8-K10-Q10-Q10-K10-Q10-Q10-Q10-K
    Other      1,652.3   
Total revenues   1,911.71,879.61,846.31,848.61,916.61,844.41,860.5
            Revenue growth   -0.3%1.9%-0.8%-0.8%3.8%2.2%9.2%
Cost of goods sold   463.4467.3470.5476.9562.2533.1524.3
Gross profit   1,448.31,412.31,375.81,371.71,354.51,311.41,336.2
            Gross margin   75.8%75.1%74.5%74.2%70.7%71.1%71.8%
Selling, general and administrative   [+] 792.4779.7759.4737.3733.4724.7737.7
Research and development   638.0640.9628.8624.4613.6634.6628.1
Equity in earnings     1.51.3  0.0
Other operating expenses   68.669.869.971.371.568.766.7
EBITDA   [+] 56.330.827.249.445.3-9.48.9
            EBITDA margin   2.9%1.6%1.5%2.7%2.4%-0.5%0.5%
Depreciation and amortization   105.4107.4108.0109.4109.2107.2105.2
EBIT   [+] -49.1-76.6-80.8-60.0-63.9-116.6-96.3
            EBIT margin   -2.6%-4.1%-4.4%-3.2%-3.3%-6.3%-5.2%
Non-recurring items   [+]  -108.0    -52.8
Interest expense, net   [+] 7.55.54.94.48.012.412.7
Other income (expense), net   4.99.710.315.57.88.57.1
Pre-tax income   56.335.6-75.4-55.6-70.7-127.1-49.0
Income taxes   2.2-3.7-11.3-66.5-902.8-917.1-903.0
            Tax rate   4.0%-10.5%15.0%119.5%1277.1%721.5%1843.0%
Net income   54.139.3-64.110.8832.1790.0854.0
            Net margin   2.8%2.1%-3.5%0.6%43.4%42.8%45.9%
   
Basic EPS   [+] $0.29$0.21($0.35)$0.06$4.58$4.36$4.73
Diluted EPS   [+] $0.29$0.21($0.35)$0.06$4.38$4.19$4.51
   
Shares outstanding (basic)   [+] 183.8183.2182.7182.2181.6181.1180.6
Shares outstanding (diluted)   [+] 187.1186.6184.0186.2189.8188.6189.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy